Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.90(2026) • Internal Medicine Benchmarking Small Language Models for Spanish... 3 min read
Article NL C.90(2026) • Internal Medicine Circadian Misalignment Correlates with Increased Gut... 3 min read
Article NL C.90(2026) • Internal Medicine Nature Medicine Study Demonstrates 3D Skeletal Motion... 3 min read
Article NL C.90(2026) • Internal Medicine Phase 3 Trial Establishes ADC and Immunotherapy... 3 min read
Article NL C.88(2026) • Internal Medicine Challenging Assumptions About Foreign-Trained... 3 min read
Article NL C.88(2026) • Internal Medicine Evaluating AI-Generated Versus Human-Authored... 3 min read